Jolanta M Siller-Matula Selected Research

human MIRN320A microRNA

10/2022

The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jolanta M Siller-Matula Research Topics

Disease

31	Hemorrhage 01/2022 - 11/2010
25	Acute Coronary Syndrome 01/2022 - 01/2011
16	Myocardial Infarction 10/2021 - 07/2013
15	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2014
14	Thrombosis (Thrombus) 04/2022 - 07/2013
11	Stroke (Strokes) 12/2021 - 07/2013
10	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 11/2008
8	Atrial Fibrillation 10/2021 - 01/2019
7	ST Elevation Myocardial Infarction 04/2022 - 10/2014
6	Ischemic Stroke 06/2020 - 02/2014
5	Heart Failure 11/2021 - 02/2014
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
4	Diabetes Mellitus 01/2021 - 07/2013
4	Inflammation (Inflammations) 01/2021 - 11/2010
3	COVID-19 01/2022 - 11/2020
3	Unstable Angina 11/2020 - 01/2017
2	Chronic Renal Insufficiency 01/2022 - 01/2021
2	Transient Ischemic Attack 12/2021 - 02/2014
2	Fibrosis (Cirrhosis) 11/2021 - 01/2021
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2021 - 06/2020
2	Atherosclerosis 12/2020 - 01/2020
2	Thromboembolism 01/2019 - 08/2012
2	Dyspnea (Shortness of Breath) 01/2018 - 11/2010
2	Vascular Diseases (Vascular Disease) 11/2013 - 02/2010
1	Neoplasms (Cancer) 10/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2022
1	Endometriosis 10/2022
1	Hypertension (High Blood Pressure) 10/2022
1	Pathologic Processes 10/2022
1	Right Ventricular Dysfunction 10/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2021
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2021
1	Diabetic Cardiomyopathies 01/2021
1	Out-of-Hospital Cardiac Arrest 01/2021
1	Cardiogenic Shock 01/2021
1	Hypertrophy 01/2021
1	Non-ST Elevated Myocardial Infarction 11/2020
1	Acute Kidney Injury (Acute Renal Failure) 06/2020

Drug/Important Bio-Agent (IBA)

17	Clopidogrel (Plavix)FDA Link 11/2020 - 11/2008
14	TicagrelorIBA 01/2022 - 11/2010
12	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2011
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 10/2011
10	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 02/2014
9	Prasugrel Hydrochloride FDA Link 01/2021 - 11/2012
7	MicroRNAs (MicroRNA)IBA 10/2022 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
6	Adenosine Diphosphate (ADP)IBA 01/2020 - 08/2012
5	AnticoagulantsIBA 01/2022 - 01/2019
4	N(4)-oleylcytosine arabinosideIBA 10/2021 - 01/2019
4	Vitamin K FDA Link 10/2021 - 01/2019
3	Dabigatran FDA Link 10/2021 - 06/2020
3	RivaroxabanIBA 01/2021 - 01/2020
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2019 - 02/2010
3	Pharmaceutical PreparationsIBA 01/2019 - 11/2008
3	vasodilator-stimulated phosphoproteinIBA 01/2018 - 11/2008
3	Thrombin FDA Link 08/2012 - 11/2010
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021 - 01/2021
2	C-Reactive ProteinIBA 01/2021 - 07/2013
2	CreatinineIBA 01/2021 - 11/2010
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020 - 01/2019
2	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 11/2016
2	Purinergic P2Y Receptor AntagonistsIBA 11/2016 - 07/2013
2	Glycoproteins (Glycoprotein)IBA 11/2016 - 07/2013
2	Abciximab (ReoPro)FDA Link 11/2016 - 07/2013
2	von Willebrand FactorIBA 11/2012 - 05/2010
1	Estrogens (Estrogen)FDA Link 10/2022
1	human MIRN320A microRNAIBA 10/2022
1	symmetric dimethylarginineIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	sirioIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	pro-brain natriuretic peptide (1-76)IBA 10/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2021
1	Warfarin (Coumadin)FDA LinkGeneric 10/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2021
1	SymportersIBA 01/2021
1	SodiumIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	CalciumIBA 01/2021
1	edoxabanIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 12/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Opiate AlkaloidsIBA 01/2020

Therapy/Procedure

27	Therapeutics 01/2022 - 10/2011
20	Percutaneous Coronary Intervention 10/2021 - 11/2008
11	Stents 04/2022 - 07/2013
4	Transcatheter Aortic Valve Replacement 12/2021 - 06/2020
4	Secondary Prevention 01/2020 - 11/2013
3	Electrodes (Electrode) 01/2017 - 09/2013
2	Drug Tapering 01/2021 - 01/2021
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 12/2017
1	Prostheses and Implants (Prosthesis) 01/2022
1	Glycemic Control 11/2021
1	Length of Stay 10/2021
1	Drug Therapy (Chemotherapy) 01/2020